PATENT CLAIM ANALYSIS

Application Number: 15975733
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-11
Patent Classification: ["424", "456000"]

Abstract:
Disclosed herein is, among other things, a soft gel vaginal pharmaceutical composition and dosage form containing solubilized estradiol for the treatment of vulvovaginal atrophy (VVA) and female sexual dysfunction (FSD).

Claim (Index 1):
A method of treating vulvovaginal atrophy (VVA), comprising vaginally administering to a subject in need thereof a liquid pharmaceutical composition comprising estradiol at a dosage of 4 mcg once daily for two weeks, then twice weekly thereafter, and increasing the dosage of estradiol if the subject does not exhibit an improvement in a clinical response for VVA.

Metadata:
- Claim Count in Document: 42.0
- Percentile: 93.0
- Lexical Diversity: 1.12121
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15975723', '15893546', '15372385', '15893542', '15893550']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7981421409088256
- 35 USC 102 Novelty (BERT): 0.6531825444678208
- Combined Prediction Score: 0.7836461812647252
- Mean Citation Score: 594.3824280000001
- Max Citation Score: 696.49207
- Similarity Product: 606.26988049406

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test